Worsening of Overactive Bladder Seen in Patients Undergoing Gender-Affirming Vaginoplasty

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 20, 2026.

via HealthDay

FRIDAY, Feb. 20, 2026 -- Patients undergoing gender-affirming vaginoplasty experience worsening of overactive bladder (OAB) with respect to their health-related quality of life (HRQoL), according to a study published online Feb. 6 in Urology.

Patrick Ho, M.D., from Mount Sinai Hospital in New York City, and colleagues conducted a retrospective longitudinal study examining changes in OAB symptoms in 53 transgender women undergoing vaginoplasty. To assess urinary symptoms before and after vaginoplasty, the 19-question Overactive Bladder Questionnaire Short-Form (OAB-q SF) was completed and the medians of OAB-q SF scores, including Symptom Bother and HRQoL subscores, were measured.

There was a median of 29 weeks from surgery to postoperative questionnaire. The researchers found that overall, 53, 21, 15, and 11 percent of participants underwent peritoneal flap vaginoplasty (PFV), penile inversion vaginoplasty, minimal depth vaginoplasty, and sigmoid vaginoplasty, respectively. Significant declines in HRQoL were noted postoperatively for all patients (96.9 versus 93.8/100). The oldest quartile of patients (44 to 71 years) experienced the largest worsening of Symptom Bother (6.7 versus 20/100) and HRQoL (96.9 versus 90.8/100), when stratified by age. PFV led to a significant decrease in HRQoL (96.9 versus 93.8/100) when stratified by vaginoplasty type.

"In a subset of patients who underwent PFV, symptoms worsened more than in those who underwent other forms of vaginoplasty," the authors write. "Similarly, older patients experienced worse symptoms postoperatively than younger patients. However, the clinical significance of these symptom changes are unclear."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-02-21 15:58

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords